Sun Pharmaceutical Industries Share Price Today - Live Blog for October 08, 2025

The stock price of Sun Pharmaceutical Industries Ltd enjoyed a significant 0.05% boost, with the current market value at ₹1,632.90 per share. This surge has not gone unnoticed by investors.

After a notable 0.07% increase, Sun Pharmaceutical Industries Ltd's shares are now trading at ₹1,632.65. This surge signifies heightened investor interest in acquiring the stock. The stock has a debt to equity ratio of 0.0327 and an ROE of 15.1334%.

The share price of Sun Pharmaceutical Industries Ltd experienced an uptrend, surging by 0.11% recently. As of now, this stock is actively trading at a current market price of ₹1,632.80 per share, attracting attention from investors.

With a -0.24% decrease, Sun Pharmaceutical Industries Ltd's share price is currently at ₹1,631.05. This development raises questions about the factors behind the decline. The stock's PE ratio is 38.2700, while the industry PE is 34.4139.

After a notable 0.06% increase, Sun Pharmaceutical Industries Ltd's shares are now trading at ₹1,635.00. This surge signifies heightened investor interest in acquiring the stock. The stock has a debt to equity ratio of 0.0327 and an ROE of 15.1334%.

Sun Pharmaceutical Industries Ltd experienced a -0.06% downturn in its share price, and it's currently trading at ₹1,634.00. This situation is generating interest among value investors who are evaluating the stock's potential.

The stock of Sun Pharmaceutical Industries Ltd has experienced a -0.14% drop, and it's now trading at ₹1,635.25 per share. This decline has sparked discussions within the investment community regarding the stock's future prospects.

Sun Pharmaceutical Industries Ltd experienced a -0.08% downturn in its share price, and it's currently trading at ₹1,637.55. This situation is generating interest among value investors who are evaluating the stock's potential.

Sun Pharmaceutical Industries Ltd witnessed a -0.08% decrease in its share price, and it is currently trading at ₹1,639.00. This decline has prompted discussions among investors regarding the stock's performance and outlook. The stock has a PE ratio of 38.2700, an ROE of 15.1334% and a debt to equity ratio of 0.0327.

The share price of Sun Pharmaceutical Industries Ltd experienced a -0.02% slump and is currently trading at ₹1,640.35. While the stock maintains a PE ratio of 38.2700, the industry PE is 34.4139, raising questions about valuation.

In a noteworthy development, Sun Pharmaceutical Industries Ltd witnessed a remarkable 0.17% increase in its share price. This surge in value has sparked heightened investor interest, with the stock currently trading at ₹1,640.70 per share. The stock has an ROE of 15.1334% and debt to equity ratio of 0.0327.

The share price of Sun Pharmaceutical Industries Ltd soared by an impressive 0.15%, marking a substantial gain for investors. At present, this stock can be acquired at a current market price of ₹1,638.00 per share.

Sun Pharmaceutical Industries Ltd shares saw a decrease of -0.16%, reaching a current market price of ₹1,634.55. Investors are evaluating the impact of this decline on the stock's overall performance and attractiveness.

The stock of Sun Pharmaceutical Industries Ltd is facing a -0.10% decline and is currently trading at ₹1,637.00 per share. Investors are closely monitoring this situation for potential signs of a turnaround.

With a -0.10% decrease, Sun Pharmaceutical Industries Ltd's share price is currently at ₹1,637.00. This development raises questions about the factors behind the decline. The stock's PE ratio is 38.2700, while the industry PE is 34.4139.

The stock of Sun Pharmaceutical Industries Ltd suffered a -0.27% decline, and it currently trades at ₹1,636.30 per share. Investors are closely monitoring this situation, looking for potential signs of recovery.

Sun Pharmaceutical Industries Ltd shares saw a -0.19% decrease, reaching a current market price of ₹1,641.30. Investors are keeping a close watch on this development, looking for potential signals of a turnaround. The stock has a PE ratio of 38.2700, an ROE of 15.1334% and a debt to equity ratio of 0.0327.

The stock of Sun Pharmaceutical Industries Ltd is on the rise, registering an impressive 0.02% increase and currently trading at ₹1,644.85 per share. Investors are taking notice of this upward momentum.

The stock of Sun Pharmaceutical Industries Ltd is facing a -0.04% decline and is currently trading at ₹1,643.35 per share. Investors are closely monitoring this situation for potential signs of a turnaround.

Investors are buzzing as Sun Pharmaceutical Industries Ltd's share price soared by an impressive 0.01%. At this moment, it's actively trading at ₹1,645.20, presenting an enticing opportunity for those in the market.

With a -0.07% decrease, Sun Pharmaceutical Industries Ltd's share price is now ₹1,643.80. Investors should examine the factors driving this decline. The stock's PE ratio is 38.2700, whereas the industry PE ratio stands at 34.4139.

With a -0.47% decrease, Sun Pharmaceutical Industries Ltd's share price is now at ₹1,640.00. The stock is currently trading at a PE of 38.2700, while the industry PE is 34.4139, prompting investors to assess its value proposition.

After a -0.47% decline, Sun Pharmaceutical Industries Ltd shares are now trading at ₹1,640.00. The stock has a PE ratio of 38.2700, an ROE of 15.1334% and a debt to equity ratio of 0.0327.

Climbing steadily, Sun Pharmaceutical Industries Ltd shares have ascended by 0.11%, reaching the current market price of ₹1,647.80. This ascent signifies increased investor sentiment. The stock has an ROE of 15.1334% and debt to equity ratio of 0.0327.

Investors are buzzing as Sun Pharmaceutical Industries Ltd's share price soared by an impressive 0.21%. At this moment, it's actively trading at ₹1,646.30, presenting an enticing opportunity for those in the market.

Sun Pharmaceutical Industries Ltd stock price decreased by -0.72%, with the current market value at ₹1,642.35 per share. Investors are assessing the stock's potential for recovery and future growth prospects.

Sun Pharmaceutical Industries Ltd's shares experienced a 0.57% uptick, and they are currently valued at ₹1,650.00, making it an attractive choice for investors. The stock has a debt to equity ratio of 0.0327 and an ROE of 15.1334%.